Sinopharm Group Co. Ltd. (1099.HK)
HKD 17.96
(-2.07%)
HKD 17.96
(-2.07%)
| Year | Gross Profit | Gross Profit Growth |
|---|---|---|
| 2023 | 48.51 Billion CNY | 2.27% |
| 2022 | 47.43 Billion CNY | 7.68% |
| 2021 | 44.05 Billion CNY | 9.24% |
| 2020 | 40.32 Billion CNY | 7.44% |
| 2019 | 37.53 Billion CNY | 20.18% |
| 2018 | 31.22 Billion CNY | 39.48% |
| 2017 | 22.38 Billion CNY | 9.75% |
| 2016 | 20.4 Billion CNY | 8.97% |
| 2015 | 18.72 Billion CNY | 14.65% |
| 2014 | 16.32 Billion CNY | 22.05% |
| 2013 | 13.37 Billion CNY | 22.26% |
| 2012 | 10.94 Billion CNY | 30.98% |
| 2011 | 8.35 Billion CNY | 43.16% |
| 2010 | 5.83 Billion CNY | 54.2% |
| 2009 | 3.78 Billion CNY | 24.7% |
| 2008 | 3.03 Billion CNY | 19.01% |
| 2007 | 2.55 Billion CNY | 28.18% |
| 2006 | 1.98 Billion CNY | 0.0% |
| Year | Gross Profit | Gross Profit Growth |
|---|---|---|
| 2024 Q1 | - CNY | -100.0% |
| 2023 Q4 | 25.24 Billion CNY | -82.59% |
| 2023 FY | 48.51 Billion CNY | 2.27% |
| 2023 Q3 | 144.96 Billion CNY | 522.97% |
| 2023 Q2 | 23.27 Billion CNY | 0.0% |
| 2022 Q4 | -119.13 Billion CNY | -182.21% |
| 2022 FY | 47.43 Billion CNY | 7.68% |
| 2022 Q2 | 21.65 Billion CNY | 0.0% |
| 2022 Q3 | 144.9 Billion CNY | 569.1% |
| 2021 FY | 44.05 Billion CNY | 9.24% |
| 2021 Q4 | 23.46 Billion CNY | 0.0% |
| 2021 Q2 | 20.58 Billion CNY | 0.0% |
| 2020 FY | 40.32 Billion CNY | 7.44% |
| 2020 Q2 | 17.24 Billion CNY | 0.0% |
| 2020 Q4 | 23.08 Billion CNY | 0.0% |
| 2019 Q4 | 20.04 Billion CNY | 0.0% |
| 2019 Q2 | 17.48 Billion CNY | 0.0% |
| 2019 FY | 37.53 Billion CNY | 20.18% |
| 2018 Q2 | 14.46 Billion CNY | 0.0% |
| 2018 FY | 31.22 Billion CNY | 39.48% |
| 2018 Q4 | 16.76 Billion CNY | 0.0% |
| 2017 Q1 | 5.55 Billion CNY | -46.55% |
| 2017 Q4 | 15.15 Billion CNY | 0.0% |
| 2017 FY | 22.38 Billion CNY | 9.75% |
| 2017 Q2 | 10.89 Billion CNY | 96.0% |
| 2016 Q4 | 10.39 Billion CNY | 0.0% |
| 2016 FY | 20.4 Billion CNY | 8.97% |
| 2016 Q2 | 10.27 Billion CNY | 0.0% |
| 2015 FY | 18.72 Billion CNY | 14.65% |
| 2015 Q4 | 9.58 Billion CNY | 0.0% |
| 2015 Q2 | 9.13 Billion CNY | 0.0% |
| 2014 FY | 16.32 Billion CNY | 22.05% |
| 2014 Q2 | 7.85 Billion CNY | 0.0% |
| 2014 Q4 | 8.47 Billion CNY | 0.0% |
| 2013 Q2 | 6.32 Billion CNY | 0.0% |
| 2013 Q4 | 7.05 Billion CNY | 0.0% |
| 2013 FY | 13.37 Billion CNY | 22.26% |
| 2012 Q4 | 3.3 Billion CNY | 22.24% |
| 2012 FY | 10.94 Billion CNY | 30.98% |
| 2012 Q3 | 2.7 Billion CNY | 0.0% |
| 2012 Q2 | 2.7 Billion CNY | 0.0% |
| 2012 Q1 | 2.7 Billion CNY | 0.0% |
| 2011 Q4 | 2.7 Billion CNY | 29.56% |
| 2011 Q3 | 2.08 Billion CNY | 0.0% |
| 2011 Q1 | 2.08 Billion CNY | 0.0% |
| 2011 Q2 | 2.08 Billion CNY | 0.0% |
| 2011 FY | 8.35 Billion CNY | 43.16% |
| 2010 Q2 | 1.45 Billion CNY | 0.0% |
| 2010 FY | 5.83 Billion CNY | 54.2% |
| 2010 Q1 | 1.45 Billion CNY | 0.0% |
| 2010 Q3 | 1.45 Billion CNY | 0.0% |
| 2010 Q4 | 2.08 Billion CNY | 43.16% |
| 2009 Q4 | 1.45 Billion CNY | 54.2% |
| 2009 FY | 3.78 Billion CNY | 24.7% |
| 2009 Q2 | 946.14 Million CNY | 0.0% |
| 2009 Q3 | 946.14 Million CNY | 0.0% |
| 2009 Q1 | 946.14 Million CNY | 0.0% |
| 2008 FY | 3.03 Billion CNY | 19.01% |
| 2008 Q4 | 946.14 Million CNY | 24.7% |
| 2008 Q3 | 758.73 Million CNY | 0.0% |
| 2008 Q2 | 758.73 Million CNY | 0.0% |
| 2008 Q1 | 758.73 Million CNY | 0.0% |
| 2007 Q2 | 637.55 Million CNY | 0.0% |
| 2007 Q3 | 637.55 Million CNY | 0.0% |
| 2007 Q4 | 758.73 Million CNY | 19.01% |
| 2007 FY | 2.55 Billion CNY | 28.18% |
| 2007 Q1 | 637.55 Million CNY | 0.0% |
| 2006 Q3 | 497.38 Million CNY | 0.0% |
| 2006 Q4 | 637.55 Million CNY | 28.18% |
| 2006 FY | 1.98 Billion CNY | 0.0% |
| 2006 Q1 | 497.38 Million CNY | 0.0% |
| 2006 Q2 | 497.38 Million CNY | 0.0% |
| 2005 Q4 | 497.38 Million CNY | 0.0% |
| Name | Gross Profit | Gross Profit Difference |
|---|---|---|
| Wanjia Group Holdings Limited | 54.74 Million HKD | -88521.991% |
| China Health Group Limited | 13.63 Million HKD | -355609.62% |
| Tai United Holdings Limited | 43.8 Million HKD | -110649.67% |